Stock Research for AXIM

AXIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AXIM Stock Chart & Research Data

The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXIM Due diligence Resources & Stock Charts

The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXIM Detailed Price Forecast - CNN Money CNN View AXIM Detailed Summary - Google Finance
Yahoo View AXIM Detailed Summary - Yahoo! Finance Zacks View AXIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AXIM Trends & Analysis - Trade-Ideas Barrons View AXIM Major Holders - Barrons
NASDAQ View AXIM Call Transcripts - NASDAQ Seeking View AXIM Breaking News & Analysis - Seeking Alpha
Spotlight View AXIM Annual Report - CompanySpotlight.com OTC Report View AXIM OTC Short Report - OTCShortReport.com
TradeKing View AXIM Fundamentals - TradeKing Charts View AXIM SEC Filings - Bar Chart
WSJ View Historical Prices for AXIM - The WSJ Morningstar View Performance/Total Return for AXIM - Morningstar
MarketWatch View the Analyst Estimates for AXIM - MarketWatch CNBC View the Earnings History for AXIM - CNBC
StockMarketWatch View the AXIM Earnings - StockMarketWatch MacroAxis View AXIM Buy or Sell Recommendations - MacroAxis
Bullish View the AXIM Bullish Patterns - American Bulls Short Pains View AXIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AXIM Stock Mentions - StockTwits PennyStocks View AXIM Stock Mentions - PennyStockTweets
Twitter View AXIM Stock Mentions - Twitter Invest Hub View AXIM Investment Forum News - Investor Hub
Yahoo View AXIM Stock Mentions - Yahoo! Message Board Seeking Alpha View AXIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AXIM - SECform4.com Insider Cow View Insider Transactions for AXIM - Insider Cow
CNBC View AXIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXIM - OTC Markets
Yahoo View Insider Transactions for AXIM - Yahoo! Finance NASDAQ View Institutional Holdings for AXIM - NASDAQ


Stock Charts

FinViz View AXIM Stock Insight & Charts - FinViz.com StockCharts View AXIM Investment Charts - StockCharts.com
BarChart View AXIM Stock Overview & Charts - BarChart Trading View View AXIM User Generated Charts - Trading View




Latest Financial News for AXIM


The Details Of The Acquisition Of Sapphire Biotech By Medical Marijuana Inc.'s AXIM Biotech
Posted on Sunday January 12, 2020

Medical Marijuana, Inc. (OTC: MJNA) announced Thursday that its investment company, AXIM Biotechnologies Inc. (OTC: AXIM), has entered a binding term sheet to acquire Sapphire Biotech, Inc., oncology research and development company. AXIM Biotechnologies and Sapphire plan to sign definitive documents for the transaction before the end of February. Sapphire is working on the development of therapeutics for preventing cancer growth and metastasis.


Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.
Posted on Thursday January 09, 2020

Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXIM") has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. ("Sapphire") as a wholly-owned subsidiary.


AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.
Posted on Wednesday January 08, 2020

SAN DIEGO, Jan. 08, 2020 -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and development,.


The Week In Cannabis: A Federal Legalization Bill, Earnings Reports And A Tax Hike In California
Posted on Sunday November 24, 2019

For the first time ever, a congressional committee in the U.S. has voted on a cannabis legalization bill. The law in question, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019, passed the House Judiciary Committee Wednesday in a 24-10 vote.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.